文献速递神经肿瘤

荧光素钠在髓母细胞瘤切除术中的应用

The application of fluorescein sodium for the resection of medulloblastoma.
PubMed 文献 · J Neurooncol · 2022-06-03

该回顾性研究分析了2016年1月至2020年12月中山大学肿瘤防治中心经手术和病理确诊的62例髓母细胞瘤患者,其中27例术中接受荧光素钠(FS,3 mg/kg),35例未接受。FS组所有病例均可见明确肿瘤荧光,微小转移灶亦可见,无FS相关副作用;两组术后症状(脑积水、头痛、呕吐、平衡障碍、小脑缄默)无显著差异,但FS组平衡障碍和小脑缄默发生率相对较低。

要点

  • FS组27例术中均可见明确肿瘤荧光,微小转移灶亦可见。
  • FS组无荧光素钠相关副作用发生。
  • 两组术后症状无显著差异,FS组平衡障碍和小脑缄默发生率相对较低。

核心结论

  • 荧光素钠在髓母细胞瘤手术中安全有效。
  • 荧光素钠的应用能否减少并发症尚待未来研究。

研究设计与样本

  • 回顾性分析2016年1月至2020年12月中山大学肿瘤防治中心经手术和病理确诊的髓母细胞瘤患者临床资料。
  • 共纳入62例患者,其中27例术中接受荧光素钠,35例未接受。
  • 术中荧光素钠剂量为3 mg/kg。

主要发现

  • 62例患者中男性42例,女性20例。
  • 荧光素钠组发病年龄9.588±7.322,非荧光素钠组13.469±10.968,P=0.198。
  • 两组在肿瘤位置、肿瘤大小、肿瘤切除程度、肿瘤组织学及术前症状(脑积水、头痛、呕吐、平衡障碍)方面无显著差异。
  • 两组术后症状(脑积水、头痛、呕吐、平衡障碍、小脑缄默)无显著差异,但荧光素钠组平衡障碍和小脑缄默发生率相对较低。
  • 荧光素钠组所有病例均可见明确肿瘤荧光,微小转移灶亦可见;无病例出现荧光素钠相关副作用。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

INTRODUCTION: Surgical resection of medulloblastoma (MB) remains a challenge. At present, a variety of tracers have been used for intraoperative tumor visualization. However, there are few reports on the intraoperative visualization of MB. Hence, we reported our experience of applying fluorescein sodium (FS) in MB surgery. METHODS: We retrospectively analyzed the clinical information of patients with MB confirmed by surgery and pathology from January 2016 to December 2020 from Sun Yat-sen University Cancer Center. A total of 62 patients were enrolled, of which 27 received intraoperative FS and 35 did not. The intraoperative dose of FS was 3 mg/kg. RESULTS: Among the 62 patients, 42 were males, and twenty were females. The age of onset in the FS group was 9.588 ± 7.322, which in the non-fluorescein sodium group was 13.469 ± 10.968, p = 0.198. We did not find significant differences in tumor location, tumor size, tumor resection, tumor histology, and preoperative symptoms (hydrocephalus, headache, vomit, balance disorder) between the groups. There was no significant difference in the postoperative symptoms (hydrocephalus, headache, vomiting, balance disorder, and cerebellar mutism). However, patients in the FS group had a relatively low incidence of balance disorder and cerebellar mutism. There was definite fluorescence of tumor in all cases of the FS group, and even the tiny metastatic lesion was visible. No case had side effects related to the use of FS. CONCLUSIONS: FS is safe and effective in MB surgery. Whether the application of FS for surgery can reduce complications remains to be studied in the future.

来源:J Neurooncol,查看原文。版权归原作者所有。

引用

  1. Chen ZH, Zhang XH, Lin FH, et al. The application of fluorescein sodium for the resection of medulloblastoma. J Neurooncol. 2022. PMID: 35657459. doi:10.1007/s11060-022-04035-2

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。